Healthpeak Properties (NYSE:DOC) Price Target Raised to $21.50 at UBS Group

Healthpeak Properties (NYSE:DOC) had its price target lifted by UBS Group from $19.00 to $21.50 in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a neutral rating on the real estate investment trust’s stock.

Other research analysts have also issued research reports about the stock. Wells Fargo & Company raised their price target on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Raymond James Financial initiated coverage on Healthpeak Properties in a report on Wednesday, June 17th. They issued a “market perform” rating for the company. Evercore lowered shares of Healthpeak Properties from an “outperform” rating to an “in-line” rating and set a $21.00 price objective for the company. in a report on Monday, May 11th. Barclays started coverage on Healthpeak Properties in a research report on Tuesday. They issued an “equal weight” rating and a $23.00 target price for the company. Finally, JPMorgan Chase & Co. boosted their target price on shares of Healthpeak Properties from $18.00 to $21.00 and gave the company a “neutral” rating in a research note on Wednesday, June 24th. Four equities research analysts have rated the stock with a Buy rating and fifteen have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $20.50.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $21.77 on Wednesday. The business’s 50 day simple moving average is $19.87 and its 200-day simple moving average is $17.96. The firm has a market capitalization of $15.01 billion, a price-to-earnings ratio of 68.05, a price-to-earnings-growth ratio of 3.42 and a beta of 1.02. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.96. Healthpeak Properties has a 12 month low of $15.70 and a 12 month high of $22.13.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, beating the consensus estimate of $0.43 by $0.02. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s quarterly revenue was up 7.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities analysts forecast that Healthpeak Properties will post 1.75 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Scott R. Bohn sold 10,989 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the completion of the transaction, the insider owned 7,636 shares in the company, valued at approximately $148,520.20. This trade represents a 59.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.23% of the stock is owned by corporate insiders.

Institutional Trading of Healthpeak Properties

A number of hedge funds have recently modified their holdings of DOC. Integrated Wealth Concepts LLC grew its holdings in shares of Healthpeak Properties by 7.3% during the 1st quarter. Integrated Wealth Concepts LLC now owns 18,084 shares of the real estate investment trust’s stock valued at $366,000 after acquiring an additional 1,231 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Healthpeak Properties by 110.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 121,881 shares of the real estate investment trust’s stock worth $2,463,000 after buying an additional 63,930 shares during the last quarter. Woodline Partners LP raised its position in Healthpeak Properties by 41.3% during the first quarter. Woodline Partners LP now owns 59,103 shares of the real estate investment trust’s stock valued at $1,195,000 after acquiring an additional 17,279 shares in the last quarter. Brown Advisory Inc. raised its position in Healthpeak Properties by 3.1% during the second quarter. Brown Advisory Inc. now owns 46,770 shares of the real estate investment trust’s stock valued at $819,000 after acquiring an additional 1,415 shares in the last quarter. Finally, Qube Research & Technologies Ltd bought a new position in Healthpeak Properties during the second quarter valued at approximately $3,117,000. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.